Form 4 for OCUL OCULAR THERAPEUTIX, INC
Accepted 2022-05-16 00:00:00 ET · period of report 2022-05-12 · accession 0001104659-22-061322 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-16 | 2022-05-12 | OCUL | LINDSTROM RICHARD L MD | Dir | M - OptEx | $1.22 | +9,469 | 99.5K | +11% | +$11.6K |
| D | 2022-05-16 | 2022-05-12 | OCUL | LINDSTROM RICHARD L MD | Dir | M - OptEx | $0.00 | -9,469 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-12 | M | A | 9,469 | $1.22 | 99,469 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-05-12 | M | D | 9,469 | $0.00 | 0 | D | $1.22 · — to 2022-10-11 | 9,469 Common Stock | (F1) The option, representing a right to purchase a total of 9,469 shares, became exercisable over four years, with 25% of the shares underlying the option vesting on November 1, 2013 and 2.0833% vesting monthly thereafter. |